P

Inventor

KNOPF JOHN

US80 patents
⚠️ This page may combine multiple inventors who share the name “KNOPF JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACCELERON PHARMA INC

33 patents
US8343933B2Jan 1, 2013

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC91 citations99
US7842663B2Nov 30, 2010

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC135 citations99
US7709605B2May 4, 2010

ActRII receptor polypeptides, methods and compositions

ACCELERON PHARMA INC145 citations99
US7612041B2Nov 3, 2009

Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth

ACCELERON PHARMA INC132 citations99
US7960343B2Jun 14, 2011

Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion

ACCELERON PHARMA INC48 citations98
US7951771B2May 31, 2011

Activin-ActRIIa antagonists and uses for promoting bone growth

ACCELERON PHARMA INC56 citations98
US10722558B2Jul 28, 2020

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC15 citations94
US10695405B2Jun 30, 2020

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC13 citations94
US10259861B2Apr 16, 2019

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC22 citations94
US9399669B2Jul 26, 2016

Variants derived from ActRIIB

ACCELERON PHARMA INC27 citations94
US9353356B2May 31, 2016

Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor

ACCELERON PHARMA INC36 citations94
US8367611B2Feb 5, 2013

Activin-actriia antagonists for inhibiting germ cell maturation

ACCELERON PHARMA INC35 citations94
US9163075B2Oct 20, 2015

Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptide

ACCELERON PHARMA INC20 citations93
US7807631B2Oct 5, 2010

Methods of promoting growth of muscle tissue using ALK7

ACCELERON PHARMA INC15 citations93
US7316998B2Jan 8, 2008

Cerberus/Coco derivatives and uses thereof

ACCELERON PHARMA INC16 citations93
US11622992B2Apr 11, 2023

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC3 citations84
US11219666B2Jan 11, 2022

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC5 citations84
US11065303B2Jul 20, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC6 citations84
US11028145B2Jun 8, 2021

ALK7:actriib heteromultimers and uses thereof

ACCELERON PHARMA INC4 citations84
US10973880B2Apr 13, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC7 citations84
US10946067B2Mar 16, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC6 citations84
US10071135B2Sep 11, 2018

Method of identifying an agent that promotes bone growth or increases bone density

ACCELERON PHARMA INC6 citations84
US9790284B2Oct 17, 2017

Methods for increasing thermogenic adipocytes

ACCELERON PHARMA INC5 citations84
US7456149B2Nov 25, 2008

ALK7 and myostatin inhibitors and uses thereof

ACCELERON PHARMA INC11 citations84
US9809636B2Nov 7, 2017

Methods for increasing red blood cell levels comprising administering BMP9

ACCELERON PHARMA INC8 citations82
US10968282B2Apr 6, 2021

Methods for screening compounds for increasing thermogenic adipocytes

ACCELERON PHARMA INC2 citations73
US10227392B2Mar 12, 2019

ALK7:ActRIIB heteromultimers and uses thereof

ACCELERON PHARMA INC3 citations73
US11059894B2Jul 13, 2021

ALK7 binding proteins and uses thereof

ACCELERON PHARMA INC1 citations72
US10501547B2Dec 10, 2019

ALK7 binding proteins and uses thereof

ACCELERON PHARMA INC3 citations72
US10344066B2Jul 9, 2019

Methods and compositions for increasing red blood cells

ACCELERON PHARMA INC3 citations71
US12343378B2Jul 1, 2025

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC0 citations63
US11497794B2Nov 15, 2022

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC0 citations63
US11318188B2May 3, 2022

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC0 citations63

KNOPF JOHN

11 patents

GRINBERG ASYA

3 patents

SEEHRA JASBIR

2 patents

WYETH CORP

1 patent

Showing the top 50 of 80 patents by PatentIndex Score.